echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Lepu Medical intends to list Xintai Technology on the main board of the Hong Kong Stock Exchange

    Lepu Medical intends to list Xintai Technology on the main board of the Hong Kong Stock Exchange

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 17, Lepu Medical (300003.
    SZ) issued an announcement stating that it intends to spin off Lepu Xintai Medical Technology (Shanghai) Co.
    , Ltd.
    (hereinafter referred to as: Xintai Technology) for listing on the main board of the Hong Kong Stock Exchange
    .

    The announcement disclosed that Xintai Technology is mainly engaged in the research and development, production and commercialization of medical devices for structural heart disease intervention
    .


    At present, the core products of aortic valve replacement and mitral valve repair clips are in clinical and preclinical stages, respectively


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.